Like A Boss: Cyril Shroff on drawing inspiration from Uday Kotak, his biggest support i.e. his wife Vandana, the power of trusting your team and much more
Inspire others to be better than you. Lead with clarity and a sense of security and confidence, says Cyril Shroff, one of the premier corporate lawyers in India.
LVB-DBS deal: Post equity capital, RBI directs LVB to write off tier-2 bonds as well
As part of the scheme of amalgamation of Lakshmi Vilas Bank with DBS Bank India, the Reserve Bank of India ( RBI) has directec the lender to also write off tier-2 bonds worth around Rs 320 crore
Bombay HC declines interim relief to LVB promoter entities in DBS merger spat
A day before the final scheme of amalgamation between Lakshmi Vilas Bank and DBS Bank India becomes effective, these promoter group entities of the ailing south India-based lender had initiated legal action against the Reserve Bank of India, the Union of India, and DBS Bank
LVB-DBS deal: Post equity capital, RBI likely to write off tier-2 bonds of LVB as well
As part of the scheme of amalgamation of Lakshmi Vilas Bank with DBS Bank India, the Reserve Bank of India ( RBI) may soon move to also write off tier-2 bonds of the ailing lender worth around Rs 320 crore
LVB promoter group entities drag RBI, Govt, DBS Bank to Bombay HC; challenge final scheme of amalgamation
The promoter group holds 6.80 per cent stake in Lakshmi Vilas Bank
LVB - DBS Bank merger: Govt approves final scheme of amalgamation; no change in equity write-off clause
According to the draft scheme of amalgamation, the entire paid-up share capital of LVB would be written off after the transaction
IPO-bound Biocon Biologics in talks with Abu Dhabi fund ADQ to raise fresh capital
If the negotiations fructify— coming two weeks after the Goldman Sachs deal—it would mark the fourth successive investment in the Kiran Mazumdar Shaw-led Biocon unit in 2020.The last fundraise was struck at a valuation of $3.94 billion.
ChrysCapital-backed Eris Lifesciences appoints former EY partner V Krishnakumar as ED & COO
Moneycontrol was the first to report the key Big 4 exit on September 29, 2020.
The LVB rescue act: How did DBS Bank India edge out other suitors?
Upfront moolah matters in rescue acts of struggling entities and as part of the draft scheme of amalgamation, DBS Bank India will also infuse upfront capital of Rs 2500 crore to aid the credit growth of the merged entity.
Blackstone-backed Embassy Office Parks looks to raise $400- $500 million; first likely institutional placement by REIT in India
In November 2019, Embassy Office Parks REIT had received a right of first offer invitation from Embassy Property Developments for the potential sale of assets in Embassy TechVillage in Bengaluru.
Goldman Sachs to invest $150 million in Biocon's IPO-bound subsidiary Biocon Biologics
As per the terms of the proposed agreement, Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion. The transaction is subject to customary approvals and conditions
Zomato ropes in Kotak Mahindra Capital, law firms for blockbuster IPO in 2021
Food delivery company Zomato and its key investors are aiming for a listing in India. If plans fructify, it will be India’s first internet IPO since IndiaMart Intermesh in 2019
Blackstone starts talks to launch IPO by Aadhar Housing Finance
The last IPO in the domestic housing finance segment happened more than two years back when Jaipur-based Aavas Financiers launched a Rs 1,640-crore issue on October 25, 2018.
10 things we learned about Future Retail’s POV in its M&A spat with Amazon
All the vital questions about the Kishore Biyani-led Future’s rebuttal on the impact of the emergency arbitrator’s order, the contentions of Amazon and the road ahead answered.
Q&A: Ranjan Pai, the billionaire entrepreneur who broke the jinx of buying a healthcare chain. What next - an IPO?
A detailed chat on the deal drivers behind the Columbia Asia deal, M&A trends in the healthcare sector and the timelines for a big-bang IPO
KKR-backed Max Healthcare engages Citi, HSBC, Credit Suisse and Kotak as investment bankers for Rs 1,200 crore QIP
Abhay Soi, a first-generation entrepreneur and turnaround expert in the hospitals segment is the Chairman of Max Healthcare. He holds a 23.26 percent stake while co-promoter private equity firm KKR holds 51.94 percent.
Harshad Mehta is a part of my growing up years: ‘Scam 1992’ director Hansal Mehta
National award-winning director Hansal Mehta on the making of the popular show, the anonymous old-timers who helped him and his team, the refreshing casting strategy, and more.
A ‘Bull’ish chat with Pratik Gandhi, the actor who brought stock market scamster Harshad Mehta to life
The Surat boy had been a struggling actor in Mumbai for long but with a breakout performance as the protagonist in 'Scam 1992: The Harshad Mehta Story', Pratik Gandhi has emerged as an artiste to watch out for.
Gland Pharma gets Sebi approval for Rs 6,000-crore IPO, set for first listing of an Indian firm with a Chinese parent
The IPO is a mixture of primary and secondary issue of shares with both China’s Fosun group and the founders of Gland Pharma due to dilute shares. Gland Pharma may look to launch the IPO in November 2020
McDonald's and Burger King supplier Mrs Bectors Foods files for a Rs 550 crore IPO
The proceeds of the Mrs Bectors Food Specialities' IPO will be used for growth capital linked to the firm’s manufacturing unit at Rajpura, Punjab and for general corporate purposes, the company said in its filing with the regulator.
Optimistic of upswing in hospitality by H12021; M&A options on table for larger hotel chains: Vikram Oberoi
EIH Ltd, which runs hotels and resorts under the Oberoi brand, drew a strong response for its recent rights issue. The issue was subscribed 160 percent. EIH, which has struck a long-term strategic alliance with Mandarin Oriental, a key player in the Far East , is betting on a turnaround in the bruised hospitality segment by H1 2021 once vaccines are readily available. With India’s busiest travel season round the corner, Moneycontrol’s Ashwin Mohan caught up exclusively with Vikram Oberoi, Managing Director and CEO of the Oberoi Group for a free-wheeling chat on consolidation in the sector, ‘revenge tourism,’ pick-up in leisure travel and much more.
Blackstone-Panchshil Realty JV in early-stage talks for REIT IPO
If the plan fructifies, this would be the third REIT IPO in India backed by Blackstone, after Embassy Office Parks and Mindspace.
PwC India Deals Leader Sanjeev Krishan elevated as chairman of Big 4 firm
Sanjeev Krishan has been with the organisation for nearly three decades and joined the firm in 1991 as an articled trainee. He became a partner at PwC India in 2006.
Will the government challenge Vodafone tax arbitration verdict? Delhi HC wants answer by November 7
The government’s stance will have huge implications — not just on other international arbitration cases involving British oil energy explorer Cairn Energy Plc and mining major Vedanta Resources but also on the India outlook of global investors and MNCs batting for tax certainty.
- Trade setup for Friday: Top 15 things to know before Opening Bell Watch more
- Business Insight | Indians eager to visit UK for Pfizer COVID-19 vaccine shots Watch more
- Ideas For Profit | Can Lumax Industries light up your portfolio? Watch more
- MDH’s Dharampal Gulati, the school dropout who became India’s highest paid FMCG CEO, is no more Watch more